// App-Quantinova.ai

P5-05-06 : Umbelliferon derivatives for androgen receptor positive triple negative breast cancer

Researchers

Presenter

  • Saswati Bhattacharya

Principal Investigators

  • Pam Westmark

  • Noah Siegel

  • Yuanqi Cai

  • Sahar Kandil

  • Andrew D Westwell

  • Christopher McGuigan

  • Ruth O'Regan

Medical Centers

  • School of Medicine and Public Health, UW-Madison, Madison, WI

  • School of Pharmacy and Pharmaceutical Medicine, Wales, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Poly(ADP-Ribose) Polymerase 1

Drug/Treatment

  • Androgen Tear

  • ribose

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved